Glocin Gel 30 gm
Product Highlights
- Clinically tested formula
- Helps reduce pimples blackheads and whiteheads
- Safe and gentle for daily use
- Pack of two tubes for uninterrupted skincare
- Same Day Delivery (order Mon-Fri before 12:00, with nominal charges)
- FREE Shipping Costs, on orders over ₹1,999
- 10 days to change your mind and free returns
- Customer Service
Description
Product Description
Glocin Gel is a dermatologist-recommended acne treatment containing a combination of Clindamycin and Nicotinamide It effectively targets acne-causing bacteria while reducing inflammation and redness The antibiotic Clindamycin works by inhibiting bacterial protein synthesis while Nicotinamide a form of Vitamin B3 soothes irritation and helps repair the skin This non greasy fast absorbing gel is ideal for mild to moderate acne management.
Best Features
- Dual-action formula with Clindamycin and Nicotinamide
- Reduces acne breakouts redness and swelling
- Controls excess oil production to prevent new acne formation
- Lightweight non greasy formula for easy absorption
- Suitable for all skin types
Categories
- Skin Care
- Acne Treatment
- Topical Medications
Key Benefits
- Effectively reduces pimples blackheads and whiteheads
- Fights acne-causing bacteria and prevents further breakouts
- Reduces inflammation redness and skin irritation
- Controls excess oil production for a clearer complexion
- Gentle and suitable for daily use
How to Use
- Cleanse your face thoroughly and pat it dry
- Apply a thin layer of Glocin Gel to the affected area
- Use once daily preferably at night or as directed by a doctor
- Avoid contact with eyes mouth and open wounds
- Wash hands before and after applying the gel
Key Ingredients
- Clindamycin 1 percent w/w An antibiotic that stops bacterial growth and treats acne
- Nicotinamide 4 percent w/w A form of Vitamin B3 that reduces inflammation and redness
Other Information
- Country of Origin: India
- Manufacturer Glowderma Lab Pvt Ltd
- Marketer Glowderma Lab Pvt Ltd
Reviews
There are no reviews yet.